*The total number of transactions refers to M&A transactions which were announced or announced & closed and where at least one of the Revenue, EBITDA or EBIT multiples have been published.
The overall decrease in the number of transactions with respect to Q2 2024 was driven by most of the sectors.
R&CP: The M&A activity decreased to 20 transactions
E&U: The M&A activity increased to 9 transactions
Healthcare: The M&A activity decreased to 14 transactions
IG&S: The M&A activity decreased to 45 transactions
MT&T: The M&A activity decreased to 54 transactions
CC&M: The M&A activity decreased to 9 transactions